Cardinal Health (CAH) Getting Somewhat Favorable Press Coverage, Accern Reports
News headlines about Cardinal Health (NYSE:CAH) have trended somewhat positive this week, according to Accern Sentiment. The research group rates the sentiment of news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Cardinal Health earned a media sentiment score of 0.12 on Accern’s scale. Accern also assigned media coverage about the company an impact score of 46.0109813280583 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
These are some of the headlines that may have impacted Accern’s scoring:
- Ex-Dividend Reminder: Cardinal Health, Raymond James Financial and CubeSmart (nasdaq.com)
- High dividend yield is attractive for Investors: Cardinal Health, Inc. (CAH) – Voice Of Analysts (analystsbuzz.com)
- Volume Boosters with Technical Valuation: Cardinal Health, Inc. (NYSE:CAH) – NASDAQ Times (nasdaqtimes.com)
- Technicals in Focus – Cardinal Health Inc (NYSE:CAH) – Alpha Beta Stock (press release) (alphabetastock.com)
Several brokerages have recently commented on CAH. ValuEngine downgraded Cardinal Health from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Evercore ISI restated an “outperform” rating on shares of Cardinal Health in a research note on Tuesday, July 4th. Zacks Investment Research upgraded Cardinal Health from a “strong sell” rating to a “hold” rating in a research note on Tuesday, June 20th. Vetr upgraded Cardinal Health from a “hold” rating to a “buy” rating and set a $77.92 target price for the company in a research note on Tuesday, June 13th. Finally, UBS AG restated a “neutral” rating and issued a $76.00 target price (down from $79.00) on shares of Cardinal Health in a research note on Thursday, August 3rd. Two research analysts have rated the stock with a sell rating, twelve have issued a hold rating and four have given a buy rating to the company’s stock. Cardinal Health currently has an average rating of “Hold” and an average target price of $76.81.
Cardinal Health (NYSE:CAH) traded up 0.47% during trading on Wednesday, hitting $68.14. 1,245,831 shares of the company’s stock traded hands. The company’s 50 day moving average is $67.69 and its 200-day moving average is $74.72. The stock has a market cap of $21.56 billion, a P/E ratio of 16.91 and a beta of 0.85. Cardinal Health has a 12 month low of $62.70 and a 12 month high of $84.88.
Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Wednesday, August 2nd. The company reported $1.31 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.24 by $0.07. The business had revenue of $32.97 billion for the quarter, compared to analysts’ expectations of $32.73 billion. Cardinal Health had a net margin of 0.99% and a return on equity of 26.20%. The business’s revenue was up 5.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.14 earnings per share. On average, analysts predict that Cardinal Health will post $4.95 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Sunday, October 15th. Shareholders of record on Monday, October 2nd will be issued a $0.4624 dividend. This represents a $1.85 dividend on an annualized basis and a yield of 2.73%. The ex-dividend date of this dividend is Friday, September 29th. Cardinal Health’s dividend payout ratio (DPR) is presently 45.79%.
COPYRIGHT VIOLATION WARNING: This piece of content was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece of content on another website, it was stolen and republished in violation of international copyright and trademark laws. The correct version of this piece of content can be read at https://www.thecerbatgem.com/2017/09/27/cardinal-health-cah-getting-somewhat-favorable-press-coverage-accern-reports.html.
Cardinal Health Company Profile
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Receive News & Stock Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related stocks with our FREE daily email newsletter.